ClinicalTrials.Veeva

Menu
F

Frenova Renal Research | Renal Associates of Baton Rouge, LLC

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Bardoxolone Methyl
VX-147
Sevelamer Hydrochloride
Phosphate
Inaxaplin
Povetacicept
Tenapanor
LNP023
Ferric Citrate
Bosutinib

Parent organization

This site is a part of Frenova Renal Research

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 16 total trials

Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN)

The purpose of this study is to evaluate the efficacy of povetacicept in adult participants compared with placebo in reducing proteinuria and preserv...

Enrolling
Immunoglobulin A Nephropathy
Drug: Placebo (matched to Povetacicept)
Drug: Povetacicept

The purpose of this study is to evaluate the efficacy, safety, tolerability, and pharmacokinetics (PK) of VX-147 in adult and pediatric participants...

Enrolling
Proteinuric Kidney Disease
Drug: Placebo
Drug: VX-147

The purpose of the study is to evaluate the efficacy, safety, and tolerability of Inaxaplin (IXP) in participants with proteinuric APOL1- mediated ki...

Enrolling
Proteinuric Kidney Disease
Drug: Inaxaplin

The study is designed as a multicenter, randomized, double-blind, placebo controlled study to demonstrate the superiority of iptacopan (LNP023) at a...

Active, not recruiting
IgA Nephropathy
Drug: Placebo
Drug: LNP023

Trial sponsors

Reata Pharmaceuticals logo
Vertex Pharmaceuticals logo
Shire logo
Ardelyx logo
Boehringer Ingelheim logo
I
K
Novartis logo
Pfizer logo
P

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems